Abstract
The study of brain structural changes in patients with Stable (sMCI) and Progressive Mild Cognitive Impairment (pMCI) has garnered significant attention from the scientific community, given the global challenge posed by Alzheimer's disease (AD) and other neurodegenerative conditions. Early detection of these diseases, particularly at the MCI stage, is crucial for implementing effective th…